Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Anticoagulant use and associated outcomes in palliative care

FY 2020-21

Summary
Background Blood thinners (anticoagulants) are commonly prescribed to prevent recurrent blood clots or to reduce the risk of stroke in patients with atrial fibrillation (the most common abnormal heart rhythm) but come with the risk of serious bleeding. Patients with advanced illness, often seen in palliative care settings, will have reasons for anticoagulant treatment, but the benefit of such treatment in this group-known to be at high risk of bleeding-is uncertain. Goals Our overall goal is to help patients with terminal illness and their healthcare providers make better informed decisions about anticoagulant treatment by performing a comprehensive assessment of anticoagulant use in patients receiving palliative care. This will include describing the prevalence and reasons for anticoagulant prescription, and characterizing the risks and benefits of treatment (focused on survival, blood clots/strokes, and bleeding). Methods Using routinely collected administrative data, we will describe anticoagulant use and its associated characteristics for all Ontarians >65 years old with advanced cancer and/or non-cancer terminal illness receiving palliative care. We will study the relationship between stopping (vs. continuing) long-term anticoagulant treatment and survival, subsequent strokes or recurrent blood clots, and bleeding episodes. Impact For individuals receiving palliative care, a patient-centred approach requires an understanding of the risks, benefits of anticoagulant treatment. We will, for the first time, describe how frequently such patients receive anticoagulants, and how these medications impact survival and the risks of future blood clots/bleeding. Our findings have the potential to change clinical practices and improve patient-centred palliative care.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
449823
Name
Chin-Yee Nicolas
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Anticoagulant use and associated outcomes in palliative care
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Anticoagulants; Atrial Fibrillation; Hemorrhage; Palliative Care; Palliative Medicine; Stroke; Terminal Care; Venous Thromboembolism
Abstract
Background Blood thinners (anticoagulants) are commonly prescribed to prevent recurrent blood clots or to reduce the risk of stroke in patients with atrial fibrillation (the most common abnormal heart rhythm) but come with the risk of serious bleeding. Patients with advanced illness, often seen in palliative care settings, will have reasons for anticoagulant treatment, but the benefit of such treatment in this group-known to be at high risk of bleeding-is uncertain. Goals Our overall goal is to help patients with terminal illness and their healthcare providers make better informed decisions about anticoagulant treatment by performing a comprehensive assessment of anticoagulant use in patients receiving palliative care. This will include describing the prevalence and reasons for anticoagulant prescription, and characterizing the risks and benefits of treatment (focused on survival, blood clots/strokes, and bleeding). Methods Using routinely collected administrative data, we will describe anticoagulant use and its associated characteristics for all Ontarians >65 years old with advanced cancer and/or non-cancer terminal illness receiving palliative care. We will study the relationship between stopping (vs. continuing) long-term anticoagulant treatment and survival, subsequent strokes or recurrent blood clots, and bleeding episodes. Impact For individuals receiving palliative care, a patient-centred approach requires an understanding of the risks, benefits of anticoagulant treatment. We will, for the first time, describe how frequently such patients receive anticoagulants, and how these medications impact survival and the risks of future blood clots/bleeding. Our findings have the potential to change clinical practices and improve patient-centred palliative care.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chin-Yee, Nicolas
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~